BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33636748)

  • 1. Genomic Analysis for the Detection of Bleeding and Thrombotic Disorders.
    Gomez K
    Semin Thromb Hemost; 2021 Mar; 47(2):174-182. PubMed ID: 33636748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of inherited bleeding disorders and thrombophilia.
    Lillicrap D
    Semin Hematol; 1999 Oct; 36(4):340-51. PubMed ID: 10530716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis.
    Megy K; Downes K; Morel-Kopp MC; Bastida JM; Brooks S; Bury L; Leinoe E; Gomez K; Morgan NV; Othman M; Ouwehand WH; Perez Botero J; Rivera J; Schulze H; Trégouët DA; Freson K
    J Thromb Haemost; 2021 Oct; 19(10):2612-2617. PubMed ID: 34355501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving interpretation of genetic testing for hereditary hemorrhagic, thrombotic, and platelet disorders.
    Lambert MP
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):76-81. PubMed ID: 33275718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the genetic determinants of hemostasis and thrombosis.
    Desch KC
    Curr Opin Hematol; 2015 Sep; 22(5):428-36. PubMed ID: 26248003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders.
    Downes K; Megy K; Duarte D; Vries M; Gebhart J; Hofer S; Shamardina O; Deevi SVV; Stephens J; Mapeta R; Tuna S; Al Hasso N; Besser MW; Cooper N; Daugherty L; Gleadall N; Greene D; Haimel M; Martin H; Papadia S; Revel-Vilk S; Sivapalaratnam S; Symington E; Thomas W; Thys C; Tolios A; Penkett CJ; ; Ouwehand WH; Abbs S; Laffan MA; Turro E; Simeoni I; Mumford AD; Henskens YMC; Pabinger I; Gomez K; Freson K
    Blood; 2019 Dec; 134(23):2082-2091. PubMed ID: 31064749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
    Wilson BJ; Miller FA; Rousseau F
    J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of rare bleeding disorders.
    Meijer K; van Heerde W; Gomez K
    Haemophilia; 2021 Feb; 27 Suppl 3():60-65. PubMed ID: 32578312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical exome sequencing in neurogenetic and neuropsychiatric disorders.
    Fogel BL; Lee H; Strom SP; Deignan JL; Nelson SF
    Ann N Y Acad Sci; 2016 Feb; 1366(1):49-60. PubMed ID: 26250888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory diagnosis of hemorrhagic and thrombotic disorders.
    Kottke-Marchant K
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):809-53. PubMed ID: 7961292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of Plant Productivity in the Post-Genomics Era.
    Thao NP; Tran LS
    Curr Genomics; 2016 Aug; 17(4):295-6. PubMed ID: 27499678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in genomic testing.
    Donoghue S; Downie L; Stutterd C
    Aust Fam Physician; 2017; 46(4):200-205. PubMed ID: 28376572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical approach to the genomics of kidney disorders.
    Hay E; Cullup T; Barnicoat A
    Pediatr Nephrol; 2022 Jan; 37(1):21-35. PubMed ID: 33675412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing genomic medicine in pathology.
    Williams ES; Hegde M
    Adv Anat Pathol; 2013 Jul; 20(4):238-44. PubMed ID: 23752086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic testing in myeloid malignancy.
    Docking TR; Karsan A
    Int J Lab Hematol; 2019 May; 41 Suppl 1():117-125. PubMed ID: 31069982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic medicine and thrombotic risk: who, when, how and why?
    Federici C; Gianetti J; Andreassi MG
    Int J Cardiol; 2006 Jan; 106(1):3-9. PubMed ID: 16102857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene and Variant Annotation for Mendelian Disorders in the Era of Advanced Sequencing Technologies.
    Chakravorty S; Hegde M
    Annu Rev Genomics Hum Genet; 2017 Aug; 18():229-256. PubMed ID: 28415856
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.